SCHEMBL17640527

SCHEMBL17640527

c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2noc(-c3ccc(N4c5ccccc5Oc5ccccc54)cc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 4/20 0.53
▸ RAB9A P51151 8/20 0.49
▸ NPC1 O15118 7/20 0.49
▸ NFKB1 P19838 4/20 0.49
▸ NFKB2 Q00653 4/20 0.49
▸ RELA Q04206 4/20 0.49
▸ SMN1; SMN2 Q16637 8/20 0.48
▸ HSD17B10 Q99714 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ PKM P14618 1/20 0.46
▸ S1PR1 P21453 1/20 0.46
▸ TP53 P04637 5/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CA2 P00918 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640607 0.99 NR1H4 (0.51) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640537 0.97 NR1H4 (0.58) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640544 0.97 NR1H4 (0.58) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640609 0.91 NR1H4 (0.44) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640623 0.90 NPC1 (0.44) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640553 0.85 NR1H4 (0.66) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640566 0.85 NR1H4 (0.66) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL17640604 0.85 S1PR1 (0.40) NR1H4RAB9ANPC1NFKB1NFKB2
SCHEMBL31059182 0.84 P2RX4 (0.39) SMN1; SMN2MAPTMEN1KMT2AKDM4E
SCHEMBL16271056 0.84 P2RX4 (0.39) SMN1; SMN2MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 NR1H4 3168/4885RAB9A 4709/4885NPC1 4857/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 NR1H4 3168/4885RAB9A 4709/4885NPC1 4857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback